MedTrace Logo

Accelerated Radiotherapy Outcomes in Women

NCT00156130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1234

Last updated 2016-05-09

No results posted yet for this study

Summary

This study is evaluating the long-term outcomes of women in a randomized trial that compared accelerated whole breast irradiation (42.5 Gy in 16 fractions over 22 days) to a longer conventional schedule of whole breast irradiation (50 Gy in 25 fractions over 35 days) following breast-conserving surgery. The outcomes evaluated will include cosmetic outcome and cardiac disease as a measure of late radiation morbidity and local breast recurrence as a measure of effectiveness.

Conditions

Interventions

RADIATION

Conventional radiotherapy schedule

50 Gy in 25 fractions over 35 days

RADIATION

Accelarated radiotherapy schedule

42.5 Gy in 16 fractions over 22 days

Sponsors & Collaborators

  • Canadian Breast Cancer Research Alliance

    collaborator OTHER

  • Ontario Clinical Oncology Group (OCOG)

    lead OTHER

Principal Investigators

  • Timothy Whelan, MD · Juravinski Cancer Centre

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00156130 on ClinicalTrials.gov